C Marcela Diaz-Montero

6PUBLICATIONS
70CO-AUTHORS
Infant and child healthMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 30, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.

|May 17, 2025
Responses to checkpoint inhibition in metastatic triple negative breast cancer driven by divergent myeloid phenotypes.

Avia D Wilkerson, Ivan Juric, Salendra Singh

|Nov 30, 2023
Clinical and Immunologic Features of Germline Pathogenic Variant-Positive Patients with Melanoma.

Alan Shen, Michelle Arbesman, Roshan Lodha

|Oct 26, 2023
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer.

Avia D Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini

|Nov 22, 2021
A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients.

Chuan Li, Yee Peng Phoon, Keaton Karlinsey

|Aug 24, 2019
Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs.

Charles S Tannenbaum, Patricia A Rayman, Paul G Pavicic

Pageof 1

Frequent Collaborators

4 joint publications

Timothy Chan

3 joint publications

Paul Pavicic

3 joint publications

Tyler J Alban

3 joint publications

Patricia Rayman